07/03/2026
For years, men were warned that testosterone therapy increases heart risk.
The data say otherwise.
The TRAVERSE trial found no significant increase in major cardiovascular events in men receiving testosterone therapy compared to placebo (7.0% vs 7.3%).
Modern guidance emphasises proper diagnosis, morning testing, symptom correlation, structured follow-up, and PSA/hematocrit monitoring.
TRT isn’t for everyone, but reflex fear isn’t evidence-based medicine.
At MHI, TRT is properly diagnosed, carefully monitored, and integrated with metabolic + cardiovascular screening.
If you feel persistently fatigued, low in drive or strength, it may be worth evaluating.
🌐 www.menshealthinst.com